{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:37:41Z","timestamp":1790750261466,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.vaccine.2006.11.060","type":"journal-article","created":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T12:10:44Z","timestamp":1166098244000},"page":"2168-2172","source":"Crossref","is-referenced-by-count":37,"title":["Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Daniel Cl\u00e1udio de Oliveira","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Fonseca","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Dione Barbosa de","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallace Pacienza","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Larraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulisses Gazos","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartira","family":"Rossi-Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.11.060_bib1","unstructured":"World Health Organization. Burden of disease in DALYs by cause, sex and mortality stratum in WHO regions, estimates for 2001. The World Health Report. Geneva: WHO; 2002. p. 192-97."},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.060_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vetpar.2004.05.019","article-title":"Assessment of an optimized dog-culling program in the dynamics of canine Leishmania transmission","volume":"122","author":"Moreira","year":"2004","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2006.11.060_bib3","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1517\/14656566.6.16.2821","article-title":"Treatment of visceral leishmaniasis","volume":"16","author":"Sundar","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"10.1016\/j.vaccine.2006.11.060_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1517\/14712598.4.9.1505","article-title":"Recent advances in vaccines for leishmaniasis","volume":"4","author":"Requena","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"5210","key":"10.1016\/j.vaccine.2006.11.060_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.060_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1538\/expanim.51.335","article-title":"Pretreatment of Leishmania homologue of receptors for activatead C kinase (LACK) promotes disease progression caused by Leishmania amazonensis","volume":"51","author":"Okuno","year":"2002","journal-title":"Exp Anim"},{"issue":"7","key":"10.1016\/j.vaccine.2006.11.060_bib7","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2006.11.060_bib8","first-page":"6156","article-title":"IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB\/c mice","volume":"161","author":"Launois","year":"1997","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.vaccine.2006.11.060_bib9","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"J Exp Med"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2006.11.060_bib10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.vaccine.2003.10.046","article-title":"A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major","volume":"22","author":"Ahmed","year":"2004","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2006.11.060_bib11","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0264-410X(02)00769-7","article-title":"DNA vaccines induce partial protection against Leishmania mexicana","volume":"21","author":"Dumonteil","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.060_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00436-005-0008-8","article-title":"Intramuscular immunization with p36 (LACK) DNA vaccine induces IFN-\u03b3 production but does not protect BALB\/c mice against Leishmania chagasi intravenous challenge","volume":"98","author":"Marques-Da-Silva","year":"2005","journal-title":"Parasitol Res"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.060_bib13","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.060_bib14","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/IAI.73.8.5286-5289.2005","article-title":"Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis","volume":"73","author":"Dondji","year":"2005","journal-title":"Infect Immun"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2006.11.060_bib15","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.11.060_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-065X.1999.tb01339.x","article-title":"Mucosal immunity and tolerance: relevance to vaccine development","volume":"170","author":"Czerkinsky","year":"1997","journal-title":"Immunol Rev"},{"issue":"48","key":"10.1016\/j.vaccine.2006.11.060_bib17","doi-asserted-by":"crossref","first-page":"17525","DOI":"10.1073\/pnas.0503428102","article-title":"A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses","volume":"102","author":"Takagi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.060_bib18","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1128\/IAI.73.11.7375-7380.2005","article-title":"Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum","volume":"73","author":"Arakawa","year":"2005","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2006.11.060_bib19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.vaccine.2004.09.010","article-title":"A novel intranasal Protollin (TM)-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice","volume":"23","author":"Chabot","year":"2005","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2006.11.060_bib20","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1016\/S0264-410X(03)00427-4","article-title":"Interferon gamma-induceing oral vaccination with Leishmania amazonensis antigens protects BALB\/c and C57BL\/6 mice against cutaneous leishmaniasis","volume":"21","author":"Pinto","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.11.060_bib21","doi-asserted-by":"crossref","unstructured":"Pinheiro RO, Pinto EF, Guedes HLM, Filho OA, Mello KA, Saraiva EM, Mendon\u00e7a SCF, Bergmann BR. Protection against cutaneous leishmania by intranasal vaccination with lipophosphoglycan. Vaccine 2006, doi:10.1016\/j.vaccine.2006.05.093, in press.","DOI":"10.1016\/j.vaccine.2006.05.093"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.060_bib22","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/IAI.72.8.4521-4527.2004","article-title":"Intranasal vaccination agaist cutaneous leishmaniasis using a particulated leishmanial antigen or LACK-DNA","volume":"72","author":"Pinto","year":"2004","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.060_bib23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.153.2.768","article-title":"Role and effect of TNF-alpha in experimental visceral leishmaniasis","volume":"153","author":"Tumang","year":"1994","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.060_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1165\/rcmb.2002-0230OC","article-title":"Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes","volume":"30","author":"Jahnsen","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.11.060_bib25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1189\/jlb.0604330","article-title":"Orally administered OVA\/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice","volume":"77","author":"Alignani","year":"2005","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.060_bib26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaci.2004.04.035","article-title":"Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides","volume":"114","author":"Farkas","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.060_bib27","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/1521-4141(200010)30:10<2935::AID-IMMU2935>3.0.CO;2-Q","article-title":"Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis","volume":"30","author":"Alexander","year":"2000","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.11.060_bib28","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"Basu","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.11.060_bib29","series-title":"Mucosal immunology","first-page":"485","article-title":"Mucosal immune responses","author":"Mcghee","year":"1999"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.060_bib30","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.4049\/jimmunol.165.10.5637","article-title":"Priming by microbial antigens from the intestinal flora determines the ability of CD4+ T cells to rapidly secrete IL-4 in BALB\/c mice infected with Leishmania major","volume":"165","author":"Julia","year":"2000","journal-title":"J Immunol"},{"issue":"31","key":"10.1016\/j.vaccine.2006.11.060_bib31","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1016\/S0264-410X(01)00188-8","article-title":"Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery","volume":"19","author":"Oh","year":"2001","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06012990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06012990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T23:48:01Z","timestamp":1683676081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06012990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0264410X06012990"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.11.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}